NasdaqGS - Nasdaq Real Time Price USD
Rallybio Corporation (RLYB)
As of 10:44 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| 5AM VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 7, 2023 | -- |
| LIEBER JONATHAN I Chief Financial Officer | Purchase | Mar 14, 2023 | 5,000 |
| PARMAR KUSH M Director | Sale | Mar 7, 2023 | -- |
Related Tickers
IKNA Ikena Oncology, Inc.
1.6800
-1.75%
GLUE Monte Rosa Therapeutics, Inc.
5.39
-2.36%
XLO Xilio Therapeutics, Inc.
0.8163
+4.79%
TNYA Tenaya Therapeutics, Inc.
1.9697
-3.46%
TSBX Turnstone Biologics Corp.
0.4901
+1.87%
LYEL Lyell Immunopharma, Inc.
1.1109
-5.05%
IPSC Century Therapeutics, Inc.
1.5600
-2.50%
DSGN Design Therapeutics, Inc.
5.54
-0.98%
OVID Ovid Therapeutics Inc.
1.1900
-2.46%
PASG Passage Bio, Inc.
0.5785
-0.17%